Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
J Hum Hypertens (2017) 31(8):5204
The absence of structured follow-up protocols is a red flag across any telehealth GLP-1 provider
Efficacy and safety of initial combination therapy with alogliptin plus metformin versus either as monotherapy in drug-nave patients with type 2 diabetes: a randomized, double-blind, 6-month study
The Danish drugmaker plans to launch Extensior, a lower-cost authorised version of Ozempic, in South Africa on 27 July through a partnership with Swiss healthcare company Acino
GC-induced miR-181d and miR-596 suppress Smad3 expression, inhibiting osteoblast differentiation
Ajith TA
US$ 21.26
US$ 29.11
US$ 28.77
US$ 27.47
US$ 22.29
US$ 24.24
US$ 23.28
